Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients
Conclusions Among older patients with AF and CAD, overall warfarin use was low. Patients ≥80 years old at highest stroke risk received warfarin in similar proportions to the overall cohort. Further investigation into optimizing antithrombotic strategies in this population is warranted.
Source: American Heart Journal - Category: Cardiology Source Type: research
More News: Angiography | Aspirin | Atrial Fibrillation | Bleeding | Cardiology | Cardiovascular | Clopidogrel | Congestive Heart Failure | Coumadin | Diabetes | Endocrinology | Heart | Heart Attack | Heart Failure | Hypertension | Ischemic Stroke | Plavix | Stroke | Warfarin